In QuotedData’s morning briefing 1 November:
- BioPharma Credit (BPCR) announced that it has made an additional investment in Insmed Incorporated following its initial loan made in October 2022. The company is investing US$60m in a new US$150m, with BioPharma-V investing US$90m. Together with the accrual and capitalization of the partial paid-in-kind interest, the company’s total exposure to Insmed will be approximately US$223.5m. Based in the US, Insmed is a publicly traded biopharmaceutical company with a current market capitalization of ~US$12 bn (Ticker: INSM – NASDAQ). Insmed is a commercial stage global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases. It recently reported trailing nine-month net sales of US$259m during the period ending 30 September 2024.
- Ecofin US Renewables Infrastructure trust (RNEW) announced that director Louisa Vincent has stepped down from the board with effect from today’s date.